QH101
/ Beijing Qinghui Liannuo Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2025
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: Anhui Provincial Hospital
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology
1 to 1
Of
1
Go to page
1